Stebbins C L, Symons J D
Department of Internal Medicine, University of California, Davis 95616.
J Appl Physiol (1985). 1995 Jan;78(1):185-90. doi: 10.1152/jappl.1995.78.1.185.
Angiotensin II (ANG II) is a potent vasoconstrictor of splanchnic and renal resistance vessels. Because ANG II increases during exercise and blood flow in the splanchnic and renal circulations decreases, we tested the hypothesis that ANG II plays a role in arterial blood pressure and regional blood flow responses to treadmill running in the miniswine. Consequently, 11 pigs were instrumented with epicardial electrocardiogram leads and left atrial and aortic catheters to assess mean arterial blood pressure (MAP), heart rate (HR), myocardial contractility, cardiac output, and regional blood flow during treadmill running. Each animal exercised for 20 min at 80% of its maximal HR reserve. Exercise was performed in the absence and presence of the ANG II AT1 receptor antagonist losartan (15-20 mg/kg). ANG II AT1 receptor blockade attenuated the MAP and systemic vascular resistance responses to dynamic exercise but had no effect on cardiac output, HR, or myocardial contractility. In addition, blood flow increased and/or regional vascular resistance decreased in the heart, kidneys, stomach, small intestine, and colon, whereas the reverse occurred in the skin and spleen. These data suggest that ANG II contributes to the increase in MAP and redistribution of cardiac output associated with dynamic exercise.
血管紧张素II(ANG II)是内脏和肾阻力血管的强效血管收缩剂。由于运动期间ANG II增加,而内脏和肾循环中的血流量减少,我们检验了ANG II在小型猪对跑步机跑步的动脉血压和局部血流反应中起作用的假设。因此,给11头猪安装了心外膜心电图导联以及左心房和主动脉导管,以评估跑步机跑步期间的平均动脉血压(MAP)、心率(HR)、心肌收缩力、心输出量和局部血流。每只动物以其最大心率储备的80%进行20分钟运动。在不存在和存在ANG II AT1受体拮抗剂氯沙坦(15 - 20 mg/kg)的情况下进行运动。ANG II AT1受体阻断减弱了对动态运动的MAP和全身血管阻力反应,但对心输出量、HR或心肌收缩力没有影响。此外,心脏、肾脏、胃、小肠和结肠的血流量增加和/或局部血管阻力降低,而皮肤和脾脏则相反。这些数据表明,ANG II有助于与动态运动相关的MAP升高和心输出量重新分布。